Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-daily vs three-times-daily mesalazine suppositories in acute ulcerative proctitis
2004-005018-35Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in ulcerative proctitis, sponsored by Dr. Falk Pharma GmbH. Started Jun 2005; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative proctitis
Beyond the preview
Go deeper on 2004-005018-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005018-35.